Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Q. Zhou

P033 a Fusion-Protein Approach Enabling Mammalian Cell Production of Tumor Targeting Protein Domains for Therapeutic Development

Journal of Thoracic Oncology

English

P063 STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma

Journal of Thoracic Oncology

English

JCSE01.18 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

Journal of Thoracic Oncology

English

P093 DNA Methylation in CTC and ctDNA Is a Promising Marker for Early Detection of Lung Cancer Metastasis

Journal of Thoracic Oncology

English

P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.01-97 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC

Journal of Thoracic Oncology

English

OA12 a Phase I Study of Novel BCL-2/BCL-xL Inhibitor APG-1252 in Patients With Advanced SCLC or Other Solid Tumor

Journal of Thoracic Oncology

English

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

Journal of Thoracic Oncology

English

P1.03-34 Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI

Journal of Thoracic Oncology

English

P042 LincRNA00494 Suppresses Non-Small Cell Lung Cancer Cell Proliferation by Regulating SRCIN1 Expression in a ceRNA Manner

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Q. Zhou

P033 a Fusion-Protein Approach Enabling Mammalian Cell Production of Tumor Targeting Protein Domains for Therapeutic Development

P063 STE029 Overcomes EGFR-TKI Resistance in Human Lung Adenocarcinoma

JCSE01.18 a Multicenter Survey of One Year Survival Among Chinese Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)

P093 DNA Methylation in CTC and ctDNA Is a Promising Marker for Early Detection of Lung Cancer Metastasis

P1.01-009 Clinically Primary and Secondary Resistance to ALK Inhibitors in ALK-Positive Advanced Non-Small-Cell Lung Cancer

P1.01-97 Cluster Trial: Ph2 Biomarker-Integrated Study of Single Agent Alpelisib, Capmatinib, Ceritinib and Binimetinib in advNSCLC

OA12 a Phase I Study of Novel BCL-2/BCL-xL Inhibitor APG-1252 in Patients With Advanced SCLC or Other Solid Tumor

MA15.01 Strong PD-L1 Expression Predicts Poor Response and De Novo Resistance to EGFR TKIs Among Non-Small Cell Lung Cancer Patients With EGFR Mutation

P1.03-34 Combined Molecular and Radiological Evaluation Unveils Three Subtypes of Disease Progression to a Third Generation EGFR TKI

P042 LincRNA00494 Suppresses Non-Small Cell Lung Cancer Cell Proliferation by Regulating SRCIN1 Expression in a ceRNA Manner